PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 4, 2026The Brown University Child & Adolescent Psychopharmacology Update0 citations

HHS critical of “overprescribing” psychiatric medications to children

View Full Paper
AKAlison Knopf

Key Points

  • The aim is to address and reduce the overprescribing of psychiatric medications among children in the U.S.
  • Announcement made at MAHA Institute summit on mental health and overmedicalization.
  • Support for patient autonomy and informed consent in treatment decisions.
  • Shift towards prevention, transparency, and holistic approaches in mental health care.
  • HHS Secretary emphasized decisive actions to confront the mental health crisis.
  • Plans include requiring informed consent and promoting shared decision-making.
  • The initiative aims to improve mental health care standards for children.

Abstract

On May 4, the U.S. Department of Health and Human Services (HHS) announced efforts to “curb psychiatric overprescribing.” The announcement made at a Make America Healthy Again (MAHA) Institute summit on mental health and overmedicalization,” was made by closing speaker, HHS Secretary Robert F. Kennedy, Jr., in particular cited psychiatric medications to children. “Today, we take clear and decisive action to confront our nation's mental health crisis by addressing the overuse of psychiatric medications—especially among children,” he said. “We will support patient autonomy, require informed consent and shared decision‐making, and shift the standard of care toward prevention, transparency, and a more holistic approach to mental health.”

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Alison Knopf (2026) studied this question.

synapsesocial.com/papers/6a2117fdd499ed480b170c57https://doi.org/10.1002/cpu.31066
Ask AI
Helpful
Bookmark
Share
View Full Paper